Our Recombinant Insulin supports major growth media suppliers’ definition for an animal free product. No animal origin component is used in the cell bank and manufacturing process. The yeast organism used for production does not contain genes or express antigens of livestock or disease agents. The trypsin is replaced by a proprietary process aid of non-animal origin. Additionally, our insulin is antibiotic free, both in terms of production facilities and on a cell bank level.
Recombinant Insulin is a key component in serum-free growth media for mammalian cells. It is used for the manufacturing of monoclonal antibodies, virus vaccines, gene therapy products and other biological drug products. Recombinant Insulin stimulates the proliferation of cells and enhances the yield.
Our Recombinant Insulin is manufactured by our parent company, Novo Nordisk, a leading supplier of insulin for over 100 years. This is the same high quality insulin that is supplied to patients all around the world for therapeutic use. Our Recimbinant Insulin is manufactured in cGMP facilities, following an ISO 9001 quality system. The large scale of our manufacturing and our highly standardised processes ensure product consistency.
The insulin is analysed according to the current European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopoeia (USP). Both Novo Nordisk and Novo Nordisk Pharmatech are regularly audited by major and minor pharmaceutical companies, as well as health authorities.
We provide a simple, ‘one-stop’ solution to regulatory compliance, providing you with everything you need in a fast and convenient way. You have our full support for your questions and requests well after supplier qualification and delivery, and throughout your whole product life cycle. Tailored to the level of service you need, our comprehensive documentation and support package includes:
Available in packing sizes from 1g to 1kg, our Recombinant Insulin is filled in our own classified room facilities. The product is dispensed into a range of HDPE plastic containers, which are placed in individual tamper-proof plastic bags. The tamper-proofed containers are placed in approved thermo containers, inside a cardboard box and packed with dry ice to ensure that the product is kept below the recommended maximum temperature during shipment.
We have enough packed off-the-shelf Recombinant Insulin in stock for at least five months of consumption, enabling us to respond immediately to your specific requirements. Our Recombinant Insulin has a five-year shelf life. Our two locally placed distribution centres – near Copenhagen, Denmark, and in Indiana, USA – ensure short lead-times and precision delivery worldwide. We are a certified Known Consignor supplier.
We recommend a titration of various insulin concentrations (0mg/L, 1mg/L, 2mg/L 5mg/L, 10mg/L, 20mg/L) with your cell line and medium in a small batch culture to find the optimal insulin concentration for your conditions. You can then evaluate if insulin addition during cell growth (e.g. day 0, day 3, day 6) further improves growth, viability or productivity.
To dissolve the powder:
The recommended concentration of Recombinant Insulin in cell culture media is 1 – 10 mg/L, depending on cell type and specific application.
Store the Recombinant Insulin at -20°C +/-5°C in its original container, avoiding humidity and sunlight, to avoid potential degradation and to ensure compliance with the product specification for the entire shelf-life period.
Our Recombinant Insulin can be stored at refrigerator temperature (+2 to +8°C) for up to 14 days in total, accumulated over its shelf life period. Within the shelf-life period, the product should not be thawed/re-frozen more than five times. In order to dispense the product for use, handling and storage at up to 25°C is allowed for up to 24 hours. The dispensed product should be kept at +2 to +8°C until use.
These recommendations and limitations apply from the time of shipment from Novo Nordisk Pharmatech and refer to the original primary packaging container.